What Redmile Group, LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1425738 · Filed Nov 16, 2026
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
| 527.7K |
| −16.5% |
| $175.5M |
| 12.8% |
SRRKScholar Rock Holding Corp | 3M | −29.6% | $146.6M | 10.7% |
STOKStoke Therapeutics, Inc. | 3.9M | −1.9% | $100.6M | 7.4% |
IMNMImmunome Inc. | 4.4M | −11.2% | $93.8M | 6.9% |
ABSIAbsci Corp | 6.7M | −1.0% | $71.9M | 5.3% |
ETRAElectra Therapeutics, Inc. | 5.4M | New | $61.1M | 4.5% |
ANNXAnnexon, Inc. | 14.3M | +20.3% | $60.4M | 4.4% |
NGNENeurogene Inc. | 1.6M | +10.6% | $43.5M | 3.2% |
RGNXRegenxbio Inc. | 5M | +15.6% | $38M | 2.8% |
STTKShattuck Labs, Inc. | 5.1M | −26.2% | $34.7M | 2.5% |
FATEFate Therapeutics Inc | 12.9M | ±0% | $30.5M | 2.2% |
SLNSilence Therapeutics plc | 2.5M | +13.7% | $26.9M | 2% |
BEAMBeam Therapeutics Inc. | 1.1M | −8.8% | $26M | 1.9% |
ATTOAttovia Therapeutics, Inc. | 1.2M | New | $19.9M | 1.5% |
AGMBAgomAb Therapeutics NV | 1.7M | −36.3% | $19.3M | 1.4% |
NUVBNuvation Bio Inc. | 3M | ±0% | $17M | 1.2% |
ADRXADARx Pharmaceuticals, Inc. | 769.3K | New | $15.3M | 1.1% |
IDYAIDEAYA Biosciences, Inc. | 381.3K | −40.4% | $14.7M | 1.1% |
ADCTADC Therapeutics SA | 11.6M | +0.5% | $14.1M | 1% |
SLDBSolid Biosciences Inc. | 1.9M | −0.2% | $14.1M | 1% |
ZYMEZymeworks Inc. | 491.7K | ±0% | $13M | 1% |
OBXObsidian Therapeutics, Inc. | 833.2K | New | $11.4M | 0.8% |
BMRNBioMarin Pharmaceutical Inc | 189.5K | −28.5% | $11.4M | 0.8% |
CLYMClimb Bio, Inc. | 974.5K | −20.5% | $11.2M | 0.8% |
CLDXCelldex Therapeutics, Inc. | 321.8K | −25.8% | $10.4M | 0.8% |
ALXOALX Oncology Holdings Inc | 7.2M | −2.8% | $10M | 0.7% |
AURAAura Biosciences, Inc. | 1.6M | −6.9% | $9.7M | 0.7% |
COGTCogent Biosciences, Inc. | 296.6K | −41.1% | $9.5M | 0.7% |
CBLLCeribell, Inc. | 386.8K | ±0% | $9.4M | 0.7% |
ODTXOdyssey Therapeutics, Inc. | 374.5K | −11.9% | $8.3M | 0.6% |
XENEXenon Pharmaceuticals Inc. | 191K | −16.7% | $7.1M | 0.5% |
LIVNLivaNova PLC | 84.1K | −9.7% | $6.4M | 0.5% |
ATRAAtara Biotherapeutics, Inc. | 636.9K | +44.2% | $5.4M | 0.4% |
INSMInsmed Inc | 42.9K | −16.3% | $4.9M | 0.4% |
EPRXEupraxia Pharmaceuticals Inc. | 519.9K | −15.0% | $4.7M | 0.3% |
DBVTDBV Technologies S.A. | 373.4K | −9.0% | $4.4M | 0.3% |
ORICOric Pharmaceuticals, Inc. | 292.8K | −19.1% | $3.9M | 0.3% |
TCGXTCGX Acquisition Corp. | 299.9K | New | $3.8M | 0.3% |
PRMEPrime Medicine, Inc. | 1.1M | −17.5% | $3.5M | 0.3% |
IVVDInvivyd, Inc. | 2.3M | −12.0% | $2M | 0.1% |
OCULOcular Therapeutix, Inc | 244K | New | $1.9M | 0.1% |
ARDXArdelyx, Inc. | 523.9K | −18.4% | $1.8M | 0.1% |
PLRXPliant Therapeutics, Inc. | 772.1K | ±0% | $833.9K | 0.1% |